Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: ANTIMETABOLITES, ANTINEOPLASTIC - THERAPEUTIC USE , . Treffer: 18
2017
Gornicec, M; Wölfler, A; Stanzel, S; Sill, H; Zebisch, A
Evidence for a role of decitabine in the treatment of myeloid sarcoma.
Ann Hematol. 2017; 96(3):505-506
Doi: 10.1007/s00277-016-2870-0
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pleyer, L; Döhner, H; Dombret, H; Seymour, JF; Schuh, AC; Beach, CL; Swern, AS; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl Spandl, S; Zebisch, A; Pichler, A; Pfeilstöcker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Int J Mol Sci. 2017; 18(2):
Doi: 10.3390/ijms18020415
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Zebisch, A; Pichler, A; Pfeilstöcker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Geissler, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
J Hematol Oncol. 2016; 9(6):39-39
Doi: 10.1186/s13045-016-0263-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Bohanes, P; Yang, D; Loupakis, F; LaBonte, MJ; Gerger, A; Ning, Y; Lenz, C; Lenz, F; Wakatsuki, T; Zhang, W; Benhaim, L; El-Khoueiry, A; El-Khoueiry, R; Lenz, HJ
Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.
Pharmacogenomics J. 2015; 15(3):226-234
Doi: 10.1038/tpj.2014.66
Web of Science
PubMed
FullText
FullText_MUG
Messina, C; Dellepiane, C; Caroti, C; Sarocchi, F; Ravetti, GL; Boccardo, F; Spina, B
A Case of Advanced Mucinous Adenocarcinoma of Bladder in an Adult Patient Treated With Capecitabine-Based Chemotherapy and Review of Literature.
Clin Genitourin Cancer. 2015; 13(5): e365-e368.
Doi: 10.1016/j.clgc.2015.04.002
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2014
Hofmann, H; von Haken, R; Werner, J; Kortes, N; Bergmann, F; Schemmer, P; Jäger, D; Radeleff, B; Schulze-Bergkamen, H
Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.
Pancreatology. 2014; 14(6):546-549
Doi: 10.1016/j.pan.2014.08.006
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Pleyer, L; Burgstaller, S; Girschikofsky, M; Linkesch, W; Stauder, R; Pfeilstocker, M; Schreder, M; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Krippl, P; Geissler, D; Voskova, D; Schlick, K; Thaler, J; Machherndl-Spandl, S; Theiler, G; Eckmüllner, O; Greil, R
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol. 2014; 93(11):1825-1838
Doi: 10.1007/s00277-014-2126-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pleyer, L; Germing, U; Sperr, WR; Linkesch, W; Burgstaller, S; Stauder, R; Girschikofsky, M; Schreder, M; Pfeilstocker, M; Lang, A; Sliwa, T; Geissler, D; Schlick, K; Placher-Sorko, G; Theiler, G; Thaler, J; Mitrovic, M; Neureiter, D; Valent, P; Greil, R
Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Leuk Res. 2014; 38(4):475-483
Doi: 10.1016/j.leukres.2014.01.006
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ress, AL; Stiegelbauer, V; Schwarzenbacher, D; Deutsch, A; Perakis, S; Ling, H; Ivan, C; Calin, GA; Rinner, B; Gerger, A; Pichler, M
Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Oncotarget. 2014; 5(18):8492-8502
Doi: 10.18632/oncotarget.2329
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Mairinger, F; Vollbrecht, C; Halbwedl, I; Hatz, M; Stacher, E; Gülly, C; Quehenberger, F; Stephan-Falkenau, S; Kollmeier, J; Roth, A; Mairinger, T; Popper, H
Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma.
J Thorac Oncol. 2013; 8(5):644-653
Doi: 10.1097/JTO.0b013e318287c224
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mairinger, F; Vollbrecht, C; Mairinger, T; Popper, H
The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma.
J Thorac Oncol. 2013; 8(8):e80-e82
Doi: 10.1097/JTO.0b013e31829b1cf9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pleyer, L; Stauder, R; Burgstaller, S; Schreder, M; Tinchon, C; Pfeilstocker, M; Steinkirchner, S; Melchardt, T; Mitrovic, M; Girschikofsky, M; Lang, A; Krippl, P; Sliwa, T; Egle, A; Linkesch, W; Voskova, D; Angermann, H; Greil, R
Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.
J Hematol Oncol. 2013; 6(4):32-32
Doi: 10.1186/1756-8722-6-32
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Hofmann, G; Langsenlehner, U; Langsenlehner, T; Glehr, M; Gerger, A; Absenger, G; Szkandera, J; Fuerst, F; Samonigg, H; Krippl, P; Renner, W
Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients.
Anticancer Res. 2011; 31(4):1373-1377
Web of Science
PubMed
2006
de Boer, NK; Reinisch, W; Teml, A; van Bodegraven, AA; Schwab, M; Lukas, M; Ochsenkühn, T; Petritsch, W; Knoflach, P; Almer, S; van der Merwe, SW; Herrlinger, KR; Seiderer, J; Vogelsang, H; Mulder, CJ; Dutch 6-TG working group
6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.
DIGESTION. 2006; 73(1): 25-31.
Doi: 10.1159/000091662
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Friess, H; Langrehr, JM; Oettle, H; Raedle, J; Niedergethmann, M; Dittrich, C; Hossfeld, DK; Stoger, H; Neyns, B; Herzog, P; Piedbois, P; Dobrowolski, F; Scheithauer, W; Hawkins, R; Katz, F; Balcke, P; Vermorken, J; van Belle, S; Davidson, N; Esteve, AA; Castellano, D; Kleeff, J; Tempia-Caliera, AA; Kovar, A; Nippgen, J
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
BMC CANCER. 2006; 6: 285
Doi: 10.1186/1471-2407-6-285
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1999
Brunner, T
[Multimodality therapy of operable pancreatic cancer].
Strahlenther Onkol. 1999; 175(8):413-4
Web of Science
PubMed
1996
Cunningham, D; Zalcberg, JR; Rath, U; Oliver, I; van Cutsem, E; Svensson, C; Seitz, JF; Harper, P; Kerr, D; Perez-Manga, G
Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.
Ann Oncol. 1996; 7(9):961-965
Doi: 10.1093/oxfordjournals.annonc.a010800
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Neumeister, P; Linkesch, W; Höfler, G; Sill, H
2-Chlorodeoxyadenosine as first-line treatment in bronchus-associated lymphoid tissue lymphoma.
Blood. 1996; 87(8):3526-3526
Doi: 10.1182/blood.V87.8.3526a.bloodjournal8783526a
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar